Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-06

Clinical Trial Update: Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of valacyclovir and Temovate Gel for the treatment of herpes labialis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temovate Gel (Clobetasol propionate gel)
  • Valacyclovir (Valacyclovir)

Snippet

Sponsor: University of Utah | Conditions: Herpes Labialis | Phase 2 | Status: COMPLETED